Chinese xenotransplantation company Qihan grabs $7.8M series A

Hangzhou Qihan Bio Inc. (Hangzhou, China) raised $7.8 million on July 23 in a series A round led by Sequoia Capital China. Arch Venture Partners, Northern Light Venture Capital, Biomatics Capital and Alta Partners also participated. ...